Aehr Test Systems (AEHR) director Laura Oliphant sells 1,717 shares at $133

Rhea-AI Filing Summary

Aehr Test Systems director Laura Oliphant reported a sale of 1,717 shares of Common Stock on 2026-08-12 in an open market or private transaction at $133.00 per share. Following this transaction, she reported holding 16,100 shares, which the company notes include shares subject to unvested restricted stock units.

Insider Trade Summary

Net Seller: 1,717 shares

Net Sell 1 txn

Insider OLIPHANT LAURA

Role Director

Sold 1,717 shs ($228K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,717	$133.00	$228K

Holdings After Transaction: Common Stock — 16,100 shares (Direct)

Footnotes (1)

1. F1. The amount reported includes shares subject to unvested restricted stock units.

Key Figures

Shares sold: 1,717 shares Sale price: $133.00 per share Shares owned after transaction: 16,100 shares +1 more

4 metrics

Shares sold 1,717 shares Common Stock sold on 2026-08-12

Sale price $133.00 per share Price for Common Stock sale on 2026-08-12

Shares owned after transaction 16,100 shares Direct holdings after sale, including unvested RSUs

Net shares sold 1,717 shares Net buy/sell direction reported as net-sell

Key Terms

restricted stock units, open market or private transaction, direct ownership

3 terms

restricted stock units financial

"The amount reported includes shares subject to unvested restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

open market or private transaction financial

"Sale in open market or private transaction"

direct ownership financial

"The reported holdings are classified as direct ownership."

FAQ

What insider transaction did AEHR director Laura Oliphant report?

Laura Oliphant reported a sale of 1,717 shares of Aehr Test Systems Common Stock on 2026-08-12 at $133.00 per share, described as a sale in an open market or private transaction.

How many AEHR shares did Laura Oliphant sell and at what price?

Laura Oliphant sold 1,717 AEHR shares at a price of $133.00 per share. The transaction is coded as a sale in an open market or private transaction under Form 4 reporting rules.

What are Laura Oliphant’s AEHR holdings after this Form 4 transaction?

After the reported sale, Laura Oliphant holds 16,100 shares of Aehr Test Systems Common Stock. A footnote states this amount includes shares subject to unvested restricted stock units.

Is Laura Oliphant’s AEHR stock ownership direct or indirect?

The reported holdings are classified as direct ownership. The Form 4 lists the ownership code as “D” for direct, with no separate entity or indirect ownership structure cited for this transaction.

Was the AEHR insider sale made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as true. There is no footnote stating the sale was made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 05:10 PM Accepted by SEC EDGAR 08/13/2026 - 05:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OLIPHANT LAURA

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CALIFORNIA 94539

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		S		1,717	D	$133	16,100(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)